Propiedad y actividad de insiders de Phathom Pharmaceuticals, Inc. (PHAT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $7.69 |
| Capitalización | $622M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-03 | Breedlove Robert Charles | F-InKind | 460 | $4K |
| 2026-07-14 | Breedlove Robert Charles | F-InKind | 1,555 | $17K |
| 2026-05-22 | Parikh Asit | G-Gift | 28,000 | |
| 2026-05-22 | Parikh Asit | G-Gift | 28,000 | |
| 2026-05-20 | Parikh Asit | M-Exempt | 17,500 | $87K |
| 2026-05-19 | Parikh Asit | A-Award | 24,122 | |
| 2026-05-20 | Parikh Asit | D-Return | 17,500 | $87K |
| 2026-05-19 | Topper James N | A-Award | 24,122 | |
| 2026-05-19 | Stenhouse Mark | A-Award | 24,122 | |
| 2026-05-19 | FIELDS HEIDI | A-Award | 24,122 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $879000 | $243.8M | $287.5M | $183.3M | $155.4M | $381.4M | $297.3M | $130.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $82000 | 0 | 0 | $1.6M | $38.8M | $78.1M |
| Inventario | 0 | 0 | -$82000 | 0 | 0 | $1.2M | $3.2M | $5.5M |
| Activos Corrientes | $902000 | $255.6M | $291.4M | $186.5M | $160.5M | $397.4M | $360.1M | $229.0M |
| Inmovilizado Material | 0 | $1.4M | $3.4M | $2.6M | $3.5M | $3.6M | $2.1M | $3.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $902000 | $257.2M | $295.1M | $189.4M | $164.8M | $413.8M | $378.3M | $259.1M |
| Cuentas por Pagar | $55000 | $699000 | $16.8M | $5.2M | $10.0M | $12.6M | $10.5M | $5.0M |
| Deuda a Corto | $1.9M | 0 | $7.4M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.2M | $3.7M | $55.5M | $18.9M | $26.2M | $38.8M | $85.7M | $132.0M |
| Deuda a Largo | 0 | $22.8M | $39.6M | $89.7M | $95.3M | $137.8M | $201.4M | $209.1M |
| Pasivos Totales | $2.2M | $29.2M | $100.8M | $117.3M | $239.6M | $486.6M | $631.9M | $697.3M |
| Reservas | -$1.3M | -$256.4M | -$385.5M | -$529.4M | -$727.1M | -$928.7M | -$1.26B | -$1.48B |
| Patrimonio Neto | -$1.3M | $228.0M | $194.3M | $72.2M | -$74.8M | -$72.8M | -$253.6M | -$438.2M |
| Deuda Total | $1.9M | $23.6M | $49.0M | $91.3M | $97.1M | $139.0M | $201.9M | $211.8M |
| Deuda Neta | $1.1M | -$220.2M | -$238.5M | -$91.9M | -$58.3M | -$242.4M | -$95.4M | $81.8M |
| Capital Circulante | -$1.3M | $251.9M | $235.8M | $167.6M | $134.3M | $358.7M | $274.4M | $96.9M |
Salud financiera
| Deuda / Patrimonio | -0.49 |
| Ratio corriente | 1.92 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -7.89 |
Rentabilidad
| Rentabilidad sobre capital | 25.70% |
| Rentabilidad sobre capital invertido | -23.36% |
| Rentabilidad sobre activos | -30.29% |
| Margen bruto | 82.92% |
| Margen operativo | -16.96% |
| Margen neto | -41.34% |
Empresas relacionadas: ANAB · BBOT · BCAX · KOD · NRIX · OCS · SANA
Explorar sector: Healthcare · Biotechnology
Más secciones de PHAT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones